-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Otsuka Pharmaceutical Says Phase 3 Fusion Results For Ulefnersen Met Primary Endpoint

Reuters·09/22/2026 12:00:01

Please log in to view news